Compare Levi Strauss & Co. (LEVI) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Levi Strauss & Co. vs Medtronic PLC — how do they compare? Levi Strauss & Co. trades at $22.95 (market cap $8.75B), while Medtronic PLC trades at $90.5 (market cap $116.07B). The key difference: Medtronic PLC is far larger — about 13.3× Levi Strauss & Co.'s market cap, and Medtronic PLC pays the higher dividend (3.18%). Which is the better fit depends on your goals.
| LEVI | MDT | |
|---|---|---|
Market Cap | $8.75B | $116.07B |
Sector | Consumer Cyclical | Health |
52-Week High | $25.53 | $105.35 |
52-Week Low | $17.92 | $73.75 |
Enterprise Value | $10.07B | $134.82B |
Dividend Yield | 2.81% | 3.18% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Levi Strauss & Co.
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver
Read more on LEVI →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
